Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial

Published:2014-08 Issue:6 Volume:24 Page:325-335
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Findling Robert L¹,Pathak Sanjeev²,Earley Willie R³,Liu Sherry²,DelBello Melissa P⁴

Affiliation:

1. Johns Hopkins Medicine and the Kennedy Krieger Institute, Baltimore, Maryland.

2. AstraZeneca Pharmaceuticals LP, Wilmington, Delaware.

3. Forest Research Institute, Inc. (formerly AstraZeneca Pharmaceuticals LP), Jersey City, New Jersey.

4. Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2013.0105

Reference43 articles.

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.

2. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

3. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder

4. A Prospective Open-Label Trial of Lamotrigine Monotherapy in Children and Adolescents with Bipolar Disorder

5. Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive Disorder

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the management of bipolar disorder in children and adolescents: an update on the literature;Expert Review of Neurotherapeutics;2024-08-05

2. QUETIAPINE;Prescriber's Guide – Children and Adolescents;2024-05-02

3. Evidence-based Psychopharmacological Treatments for Pediatric Bipolar Disorder;Journal of Dr Behcet Uz Children s Hospital;2024-04-15

4. Bipolare Störungen im Kindes- und Jugendalter;Springer Reference Medizin;2024

5. Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression;CNS Neuroscience & Therapeutics;2023-11-06